Literature DB >> 16051943

Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab.

Lee M Ellis1, Steven A Curley, Axel Grothey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16051943     DOI： 10.1200/JCO.2005.23.754

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  35 in total

1.  Two-photon fluorescence vascular bioimaging with new bioconjugate probes selective toward the vascular endothelial growth factor receptor 2.

Authors:  Carolina D Andrade; Ciceron O Yanez; Hyo-Yang Ahn; Takeo Urakami; Mykhailo V Bondar; Masanobu Komatsu; Kevin D Belfield
Journal:  Bioconjug Chem       Date:  2011-10-04       Impact factor: 4.774

Review 2.  [Colorectal liver metastases. Neoadjuvant chemotherapy: aspects of medical and surgical oncology].

Authors:  Anke C Reinacher-Schick; W O Bechstein
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

Review 3.  Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.

Authors:  Christopher Christophi; Nadia Harun; Theodora Fifis
Journal:  J Gastrointest Surg       Date:  2008-01-08       Impact factor: 3.452

Review 4.  Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.

Authors:  Jianmin Xu; Xinyu Qin; Jianping Wang; Suzhan Zhang; Yunshi Zhong; Li Ren; Ye Wei; Shaochong Zeng; Deseng Wan; Shu Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-28       Impact factor: 4.553

5.  Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosing.

Authors:  David C Turner; Fariba Navid; Najat C Daw; Shenghua Mao; Jianrong Wu; Victor M Santana; Michael Neel; Bhaskar Rao; Jennifer Reikes Willert; David M Loeb; K Elaine Harstead; Stacy L Throm; Burgess B Freeman; Clinton F Stewart
Journal:  Clin Cancer Res       Date:  2014-03-17       Impact factor: 12.531

6.  Mechanisms regulating colorectal cancer cell metastasis into liver (Review).

Authors:  Ketao Jin; Weili Gao; Yanyan Lu; Huanrong Lan; Lisong Teng; Feilin Cao
Journal:  Oncol Lett       Date:  2011-09-30       Impact factor: 2.967

Review 7.  Treatment recommendations for metastatic colorectal cancer.

Authors:  Enrique Aranda; Albert Abad; Alfredo Carrato; Andrés Cervantes; Jesús García-Foncillas; Pilar García Alfonso; Rocío García Carbonero; Auxiliadora Gómez España; Josep M Tabernero; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

8.  Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases.

Authors:  Matteo Donadon; Jean-Nicolas Vauthey; Evelyne M Loyer; Chusilp Charnsangavej; Eddie K Abdalla
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

9.  Bevacizumab treatment before resection of colorectal liver metastases: safety, recovery of liver function, pathologic assessment.

Authors:  K Dede; T Mersich; I Besznyák; A Zaránd; F Salamon; Z S Baranyai; L Landherr; F Jakab; A Bursics
Journal:  Pathol Oncol Res       Date:  2013-02-19       Impact factor: 3.201

10.  [Bevacizumab (Avastin) related surgical complications: comment to Abbrederis K et al. (2007)].

Authors:  F Lordick; J R Siewert
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.